Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Lung Cancer Genetics

Pulmonary Transplant (Lung Transplant)

Lung Cancer and Electrolyte Imbalances

Lung Cancer in Women: Understanding the Increasing Risk

Immunotherapy: The Future of Lung Cancer Treatment?

Everything You Need to Know About Giving Up Cigarettes

Lung Cancer Research

Carcinogens in Cigarette Smoke

Lung Cancer Questions

Lung Cancer: Radiotherapy and Chemotherapy

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

See more featured articles »

Types of Lung Cancer Surgery

Lung Cancer Diagnosis

Lung Cancer Risk Factors

What Causes Lung Cancer in Non-Smokers?

Lymph Nodes in Lung Cancer

How to Prevent Lung Cancer

What are the Survival Rates for Lung Cancer?

Lung Cancer Pathogenesis

Lung Cancer Screening Procedure

Lung Cancer Causes

Secondary Lung Cancer

Epidemiology of Lung Cancer

Lung Cancer Symptoms

Pulmonary Resection in Lung Cancer

Lung Cancer Treatments

Lung Plethysmography Procedure

Palliative and End-of-Life Care in Lung Cancer

Latest Lung Cancer News and Research

Air pollution in pregnancy raises birth risks differently across trimesters

A population-based study of 26,582 live singleton births in Madrid found that associations between NO₂ exposure and adverse birth outcomes varied by pregnancy stage, with key patterns emerging in the first and third trimesters.

6 Aug 2026

Tuft cell-like cancers exhibit unique biological characteristics across multiple organs

A growing body of evidence suggests that a rare epithelial cell type known as the tuft cell may play a far more significant role in cancer than previously recognized.

6 Aug 2026

Stanford researcher receives NIH grant to develop molecular imaging agent for localizing lung tumors during surgery

Lung cancer remains the leading cause of cancer-related deaths, and surgery is a critical treatment option for early-stage disease.

6 Aug 2026

New AI framework ASTRA-Net maps hidden peripheral airways for bronchoscopy

Lung cancer is the most diagnosed cancer globally and is one of the leading causes of cancer-related deaths.

6 Aug 2026

Experimental drug CS18 shows promise for overcoming cancer treatment resistance

Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.

5 Aug 2026

Global surveys reveal little progress in tobacco risk awareness over two decades

Across 46 countries, adults who smoked showed high awareness that tobacco causes lung cancer but substantially lower knowledge of cardiovascular and secondhand smoke harms. Knowledge changed little overall across two decades, supporting stronger health warnings, mass media campaigns and enforced smoke-free policies.

5 Aug 2026

Obscure X chromosome protein emerges as key driver in several cancers

A little-known protein encoded on the X chromosome is attracting growing attention for its potential role in cancer development and treatment.

5 Aug 2026

Novel drug puts cancer cells under extreme metabolic stress

Cancer cells have a voracious appetite for sugar-using it to fuel their rapid growth. This is why many scientists have tried to develop drugs that block cancer cells' metabolism by cutting off their sugar supply.

5 Aug 2026

Study of lung immune cells uncovers roots of autoimmune disease

A massive analysis of immune cells in human tissue is yielding clues to the root cause of lung and autoimmune diseases.

3 Aug 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

31 Jul 2026

New blood test could save millions through early tuberculosis detection

A new study presented today at ADLM 2026 in Anaheim, California found that a simple blood test could accurately identify tuberculosis (TB) - a leading cause of death worldwide - among patients with varying degrees of exposure to the disease.

28 Jul 2026

Noncombustible nicotine products replace cigarette use among young adults

As cigarette smoking reaches historic lows in the U.S., new research from MUSC Hollings Cancer Center suggests a fundamental shift in tobacco use is driving that trend.

27 Jul 2026

Study links inherited genetics to cancer susceptibility and progression

Scientists have found the first direct evidence of the powerful role our genetic makeup plays in influencing our risk of cancer, with inherited genes interacting with acquired genetic mutations to shape how tumors evolve.

26 Jul 2026

RNA-based testing can improve detection of key lung cancer biomarkers

New research has shown that RNA-based testing can improve the detection and interpretation of clinically actionable genomic alterations leading to MET exon 14 skipping in lung cancer patients—important biomarkers that may be missed by DNA-only approaches.

23 Jul 2026

Ancient immune protein C3 boosts cancer immunotherapy within tumors

An ancient molecule that existed long before the blood circulation system evolved, has been found to support cancer immunotherapy.

23 Jul 2026

Former smokers retain lasting lung damage despite quitting

A new study by a team of McGill researchers could help explain why people who have quit smoking remain at elevated risk of lung disease long after their last cigarette.

22 Jul 2026

Study reveals sex-based protein differences across lung cancer types

Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma disproportionately affects males while adenocarcinoma occurs more frequently in females.

21 Jul 2026

City of Hope launches trial to map how tumors change during immunotherapy resistance

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S. News & World Report, has opened an innovative Phase 2 clinical trial designed to map how tumors change as they begin to resist immunotherapy, treatment that improves the immune system's ability to fight disease.

21 Jul 2026

New approach enhances radiotherapy by disabling cancer's DNA repair machinery

Cancer treatments like radiation and chemotherapy work by doing one main thing: shredding the DNA of cancer cells so they can no longer multiply.

16 Jul 2026

Vaping or smoking found to reduce fitness in young people by 15%

Young people who vape or smoke cigarettes have reduced blood vessel functionality, breathing efficiency and exercise capacity compared to those who have never smoked or vaped, according to a study published today in ERJ Open Research.

14 Jul 2026